These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15816428)

  • 1. Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology.
    Sotiropoulos GC; Malagó M; Molmenti E; Paul A; Nadalin S; Brokalaki EI; Verhagen R; Dirsch O; Gerken G; Lang H; Broelsch CE
    Hepatogastroenterology; 2005; 52(62):329-32. PubMed ID: 15816428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in staging for hepatocellular carcinoma after radiofrequency ablation prior to liver transplantation as found in the explanted liver.
    Schroeder T; Sotiropoulos GC; Molmenti EP; Kuehl H; Cicinnati VR; Schmitz KJ; Kóbori L; Paul A; Mathé Z
    Hepatogastroenterology; 2011; 58(112):2029-31. PubMed ID: 22234073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
    Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
    Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
    Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
    Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M
    Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of post-operative transcatheter arterial chemoembolization in hepatocellular carcinoma with different pathological characteristics].
    Xi T; Yan ZL; Wang K; Li J; Xia Y; Shen F; Wu MC
    Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):587-90. PubMed ID: 17688789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma.
    Otto G; Heise M; Moench C; Herber S; Bittinger F; Schuchmann M; Hoppe-Lotichius M; Pitton M
    Transplant Proc; 2007 Mar; 39(2):537-9. PubMed ID: 17362776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study.
    Dharancy S; Boitard J; Decaens T; Sergent G; Boleslawski E; Duvoux C; Vanlemmens C; Meyer C; Gugenheim J; Durand F; Boillot O; Declerck N; Louvet A; Canva V; Romano O; Ernst O; Mathurin P; Pruvot FR
    Liver Transpl; 2007 May; 13(5):665-71. PubMed ID: 17427172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
    Pérez Saborido B; Meneu JC; Moreno E; García I; Moreno A; Fundora Y
    Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment before liver transplantation for HCC.
    Belghiti J; Carr BI; Greig PD; Lencioni R; Poon RT
    Ann Surg Oncol; 2008 Apr; 15(4):993-1000. PubMed ID: 18236111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
    de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
    J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
    Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
    Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
    Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
    Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.